Anti-obese and anti-diabetic effects of a mixture of daidzin and glycitin on C57BL/6J mice fed with a high-fat diet

References

• Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell. 2001;104:531–543.10.1016/S0092-8674(01)00240-9
   PubMed Web of Science ®Google Scholar
• Orgaard A, Jensen L. The effects of soy isoflavones on obesity. Exp. Biol. Med. 2008;233:1066–1080.10.3181/0712-MR-347
   PubMed Web of Science ®Google Scholar
• Smyth S, Heron A. Diabetes and obesity: the twin epidemics. Nat. Med. 2006;12:75–80.10.1038/nm0106-75
   PubMed Web of Science ®Google Scholar
• Messina M. Soy, soy phytoestrogens (isoflavones), and breast cancer. Am. J. Clin. Nutr. 1999;70:574–575.
   PubMed Web of Science ®Google Scholar
• Tham DM, Gardner CD, Haskell WL. Clinical review 97: potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J. Clin. Endocrinol. Metab. 1998;83:2223–2235.
   PubMed Web of Science ®Google Scholar
• Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am. J. Clin. Nutr. 2002;76:1191–1201.
   PubMed Web of Science ®Google Scholar
• Ishimi Y. Soybean isoflavones in bone health. Forum. Nutr. 2009;61:104–116.10.1159/000212743
   PubMed Web of Science ®Google Scholar
• Mori M, Aizawa T, Tokoro M, Miki T, Yamori Y. Soy isoflavone tablets reduce osteoporosis risk factors and obesity in middle-aged Japanese women. Clin. Exp. Pharmacol. Physiol. 2004;31:S39–S41.10.1111/cep.2004.31.issue-s2
   Google Scholar
• Tutel’ian VA, Pavliuchkova MS, Pogozheva AV, Vorob’eva L, Derbeneva SA. The study of soy isoflavone metabolism in patients with cardiovascular diseases. Vopr. Pitan. 2002;71:20–22.
   PubMedGoogle Scholar
• Kim MH, Bae YJ. Dietary isoflavone intake, urinary isoflavone level, and their relationship with metabolic syndrome diagnostic components in Korean postmenopausal women. Clin. Nutr. Res. 2013;2:59–66.10.7762/cnr.2013.2.1.59
   PubMedGoogle Scholar
• Klejdus B, Mikelová R, Petrlová J, Potesil D, Adam V, Stiborová M, Hodek P, Vacek J, Kizek R, Kubán V. Evaluation of isoflavone aglycon and glycoside distribution in soy plants and soybeans by fast column high-performance liquid chromatography coupled with a diode-array detector. J. Agric. Food Chem. 2005;53:5848–5852.10.1021/jf0502754
   PubMed Web of Science ®Google Scholar
• Wang HJ, Murphy PA. Isoflavone content in commercial soybean foods. J. Agric. Food Chem. 1994;42:1666–1673.10.1021/jf00044a016
   Web of Science ®Google Scholar
• Choi I, Kim Y, Park Y, Seog H, Choi H. Anti-obesity activities of fermented soygerm isoflavones by Bifidobacterium breve. BioFactors. 2007;29:105–112.10.1002/biof.v29:2/3
   PubMed Web of Science ®Google Scholar
• Izumi T, Piskula MK, Osawa S, Obata A, Tobe K, Saito M. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J. Nutr. 2000;130:1695–1699.
   PubMed Web of Science ®Google Scholar
• Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J. Nutr. 2001;131:1362–1375.
   PubMed Web of Science ®Google Scholar
• Zubik L, Meydani M. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am. J. Clin. Nutr. 2003;77:1459–1465.
   PubMed Web of Science ®Google Scholar
• Kim DH, Jung HA, Park SJ, Kim JM, Lee S, Choi JS, Cheong JH, Ko KH, Ryu JH. The effects of daidzin and its aglycon, daidzein, on the scopolamine-induced memory impairment in male mice. Arch. Pharm. Res. 2010;33:1685–1690.10.1007/s12272-010-1019-2
   PubMed Web of Science ®Google Scholar
• Kim SH, Heo JH, Kim YS, Kang SS, Choi JS, Lee SM. Protective effect of daidzin against d-galactosamine and lipopolysaccharide-induced hepatic failure in mice. Phytother. Res. 2009;23:701–706.10.1002/ptr.v23:5
   PubMed Web of Science ®Google Scholar
• Meezan E, Meezan EM, Jones K, Moore R, Barnes S, Prasain JK. Contrasting effects of puerarin and daidzin on glucose homeostasis in mice. J. Agric. Food Chem. 2005;53:8760–8767.10.1021/jf058105e
   PubMed Web of Science ®Google Scholar
• Li XH, Zhang JC, Sui SF, Yang MS. Effect of daidzin, genistin, and glycitin on osteogenic and adipogenic differentiation of bone marrow stromal cells and adipocytic transdifferentiation of osteoblasts. Acta. Pharmacol. Sin. 2005;26:1081–1086.10.1111/aphs.2005.26.issue-9
   PubMed Web of Science ®Google Scholar
• Uesugi T, Toda T, Tsuji K, Ishida H. Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy isoflavones, daidzin, genistin, and glycitin. Biol. Pharm. Bull. 2001;24:368–372.10.1248/bpb.24.368
   PubMed Web of Science ®Google Scholar
• Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957;226:497–509.
   PubMed Web of Science ®Google Scholar
• Soga T, Baran R, Suematsu M, Ueno Y, Ikeda S, Sakurakawa T. Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J. Biol. Chem. 2006;281:16768–16776.10.1074/jbc.M601876200
   PubMed Web of Science ®Google Scholar
• Kumar S, Korsey JA, Muesing RA, Porter JW. Comparative studies of the pigeon liver fatty acid synthetase complex and its subunits. J. Biol. Chem. 1970;245:4732–4744.
   PubMed Web of Science ®Google Scholar
• Carey EM, Dils R. Fatty acid biosynthesis. V. Purification and characterisation of fatty acid synthetase from lactating-rabbit mammary gland. Biochim. Biophys. Acta. Lipid Lipid Met. 1970;210:371–387.10.1016/0005-2760(70)90033-0
   PubMed Web of Science ®Google Scholar
• Ae Park S, Choi MS, Cho SY, Seo JS, Jung UJ, Kim MJ. Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sci. 2006;79:1207–1213.10.1016/j.lfs.2006.03.022
   PubMed Web of Science ®Google Scholar
• Hodgson JM, Puddey IB, Beilin LJ, Mori TA, Croft KD. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. J. Nutr. 1998;128:728–732.
   PubMed Web of Science ®Google Scholar
• Hsu CS, Chiu WC, Yeh SL. Effects of soy isoflavone supplementation on plasma glucose, lipids and antioxidant enzyme activities in streptozotocin-induced diabetic rats. Nutr. Res. 2003;23:67–75.10.1016/S0271-5317(02)00386-X
   Web of Science ®Google Scholar
• Crespillo A, Alonso M, Vida M, Pavón FJ, Serrano A, Rivera P, Romero-Zerbo Y, Fernández-Llebrez P, Martínez A, Pérez-Valero V, Bermúdez-Silva FJ, Suárez J, de Fonseca FR. Reduction of body weight liver steatosis and expression of stearoyl-CoA desaturase 1 by the isoflavone daidzein in diet-induced obesity. Br. J. Pharmacol. 2011;164:1899–1915.10.1111/j.1476-5381.2011.01477.x
   PubMed Web of Science ®Google Scholar
• Guo Y, Wu G, Su X, Yang H, Zhang J. Antiobesity action of a daidzein derivative on male obese mice induced by a high-fat diet. Nutr. Res. 2009;29:656–663.10.1016/j.nutres.2009.09.005
   PubMed Web of Science ®Google Scholar
• Harte RA, Kirk EA, Rosenfeld ME, LeBoeuf RC. Initiation of hyperinsulinemia and hyperleptinemia is diet dependent in C57BL/6 mice. Horm. Metab. Res. 1999;31:570–575.10.1055/s-2007-978797
   PubMed Web of Science ®Google Scholar
• Kopelman PG. Obesity as a medical problem. Nature. 2000;404:635–643.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Na X, Li L, Zhao X, Cui H. Isoflavone reduces body weight by decreasing food intake in ovariectomized rats. Ann. Nutr. Metab. 2009;54:163–170.10.1159/000217812
   PubMed Web of Science ®Google Scholar
• Hamden K, Jaouadi B, Carreau S, Aouidet A, Elfeki A. Therapeutic effects of soy isoflavones on alpha-amylase activity, insulin deficiency, liver–kidney function and metabolic disorders in diabetic rats. Nat. Prod. Res. 2011;25:244–255.10.1080/14786411003683117
   PubMed Web of Science ®Google Scholar
• Lee JS. Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocin-induced diabetic rats. Life Sci. 2006;79:1578–1584.10.1016/j.lfs.2006.06.030
   PubMed Web of Science ®Google Scholar
• Sosic-Jurjevic B, Filipovic B, Ajdzanovic V, Brkic D, Ristic N, Stojanoski MM, Nestorovic N, Trifunovic S, Sekulic M. Subcutaneously administrated genistein and daidzein decrease serum cholesterol and increase triglyceride levels in male middle-aged rats. Exp. Biol. Med. 2007;232:1222–1227.10.3181/0703-BC-82
   Web of Science ®Google Scholar
• Zimmermann C, Cederroth CR, Bourgoin L, Foti M, Nef S. Prevention of diabetes in db/db mice by dietary soy is independent of isoflavone levels. Endocrinology. 2012;153:5200–5211.10.1210/en.2012-1490
   PubMed Web of Science ®Google Scholar
• Choi MS, Jung UJ, Yeo J, Kim MJ, Lee MK. Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diabetes Metab. Res. Rev. 2008;24:74–81.10.1002/(ISSN)1520-7560
   PubMed Web of Science ®Google Scholar
• Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature. 1997;389:610–614.
   PubMed Web of Science ®Google Scholar
• Friedman JM. The function of leptin in nutrition, weight, and physiology. Nutr. Rev. 2002;60:1–14.10.1301/002966402320634878
   PubMed Web of Science ®Google Scholar
• Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1995;1:1155–1161.10.1038/nm1195-1155
   PubMed Web of Science ®Google Scholar
• Jung UJ, Lee MK, Jeong KS, Choi MS. The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J. Nutr. 2004;134:2499–2503.
   PubMed Web of Science ®Google Scholar
• Arora A, Nair MG, Strasburg GM. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch. Biochem. Biophys. 1998;356:133–141.10.1006/abbi.1998.0783
   PubMed Web of Science ®Google Scholar